Xoft, a subsidiary of iCAD, Inc.

About Xoft, a subsidiary of iCAD, Inc.

The Xoft® Electronic Brachytherapy System® is an isotope-free radiation treatment cleared by the FDA for use anywhere in the body, including non-melanoma skin cancer, brain tumors, early stage breast cancer, and gynecological cancers. It utilizes a proprietary miniaturized x-ray as the radiation source that delivers precise treatment directly to cancerous areas while sparing healthy tissue and organs. The Xoft System can be administered as a single course of radiation therapy during surgery in the form of intraoperative radiation therapy (IORT) or in the form of partial breast irradiation (APBI). The Xoft System does not require a shielded environment and the system’s relatively small size and mobility enable it to be used in virtually any clinical setting. A post-market study is underway to assess the safety and efficacy of IORT with the Xoft System. Xoft, Inc. is a wholly owned subsidiary of iCAD, Inc. For more information about Xoft visit www.xoftinc.com.

Website	http://www.xoftinc.com
Employees	11-50 employees View all Xoft, a subsidiary of iCAD, Inc. employees
Industry	Medical Equipment Manufacturing
Revenue	$10M–$50M
Phone number	(603) 882-5200
Headquarter	101 Nicholson Lane, San Jose, CA 95134, US
Founded	1998
Keywords	Healthcare, Skin Cancer, Breast Cancer, Cancer Treatment, Iort, Brachytherapy, Radiation Treatment, Endometrial Cancer, Accelerated Partial Breast Irradiation (Apbi), Electronic Brachytherapy (Ebx), Intraoperative Radiation Therapy (Iort)